Jason Yongsheng Chan, MD,PhD Disclosures: Consulting Fee-Takeda Pharmaceuticals (Any division) (Relationship has ended)|Consulting Fee-AbbVie (Any division) (Relationship has ended)|Consulting Fee-Janssen (Any division) (Relationship has ended)|Consulting Fee-Meiji (Relationship has ended)|Consulting Fee-Beigene (Relationship has ended)|Consulting Fee-Merck (Any division) (Relationship has ended)|Consulting Fee-Novartis Corporation Pharmaceuticals (Relationship has ended)|Consulting Fee-Roche (Any division) (Relationship has ended)|Consulting Fee-AstraZeneca (Any division) (Relationship has ended)|Grant or research support-SymBio Pharmaceuticals - 12/20/2024 Faculty Bio